nach oben

Erschienen in:

2019 | OriginalPaper | Buchkapitel

6. Downstream Processing for Biopharmaceuticals Recovery

verfasst von : Anu Mehta

Erschienen in: Pharmaceuticals from Microbes

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

The invention of genetic engineering tools has given birth to a new type of pharmaceuticals known as biopharmaceuticals. These are the drug molecules that have therapeutic effects and are synthesised in biological cell systems. Drug like recombinant insulin is a prominent prototype example of biopharmaceutical which is commonly available in the market at cheap prices for diabetic patients, globally. The production of these therapeutic molecules differs from chemically synthesised low molecular weight drugs. Upstream and downstream processes altogether comprise the production process of biopharmaceuticals. The downstream processing costs 70% of the total production cost of a particular biopharmaceutical, largely contributed by expensive chromatographic techniques such as affinity, hydrophobic interaction, ion exchange and size exclusion. Although chromatography is a reliable and conventional approach to carry out single step purification of biopharmaceuticals, the columns are run in a series to increase the purification fold. This makes the process tedious, and problems like diffusional spreading and resolution are also observed with chromatography procedures. The concern is important as we aim to bring various biopharmaceuticals into market that can treat innumerable diseases at a cheap price.

The current chapter emphasises the process and technology related to the upstream process and the three chronological steps – initial recovery, purification and polishing – involved in downstream processing of biopharmaceuticals. The chapter encompasses the hurdles encountered in the downstream processing in particular with chromatography process that makes high-quality production of biopharmaceuticals an expensive affair thus making it difficult to reach the public. New technologies designed to offer faster and cheaper purification such as aqueous two-phase extraction system, and nano-magnetic-based antibodies separation system have been discussed further. Moreover, we have reviewed and emphasised the requirement of using combination of physical, mathematical, biological and computational approaches, which can help to design efficient production and purification systems for the ample, cheap and continuous market supply of this new category of drugs.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Microbial Modifications of Flavonols

Nächstes Kapitel Engineering Streptomyces peucetius for Doxorubicin and Daunorubicin Biosynthesis

Albertsson PA (1970) Partition of cell particles and macromolecules in polymer two-phase system. Adv Protein Chem 24:309–341. https://doi.org/10.1016/S0065-3233(08)60244-2 CrossRef

Alford JR, Kendrick BS, Carpenter JF, Randolph TW (2008) High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. aggregation kinetics. J Pharm Sci 97(8):3005–3021. https://doi.org/10.1002/jps.21205 CrossRef

Arakawa T, Tsumoto K, Nagase K, Ejima D (2007) The effects of arginine on protein binding and elution in hydrophobic interaction and ion-exchange chromatography. Protein Expr Purif 54(1):110–116. https://doi.org/10.1016/j.pep.2007.02.010 CrossRef

Aumann L, Morbidelli M (2007) A continuous multicolumn countercurrent solvent gradient purification (MCSGP) process. Biotechnol Bioeng 98(5):1043–1055. https://doi.org/10.1002/bit.21527 CrossRef

Azevedo AM, Aires-Barros MR (2011) New platforms for downstream processing of biopharmaceuticals. 1st Portuguese Meeting in Bioengineering, February 2011 Portuguese chapter of IEEE EMBS Instituto Superior Técnico, Technical University of Lisbon

Azevedo AM, Rosa PA, Ferreira IF, Aires-Barros MR (2007) Optimisation of aqueous two-phase extraction of human antibodies. J Biotechnol 132(2):209–217. https://doi.org/10.1016/j.jniotec.2007.04.002 CrossRef

Bailey JE, Ollis DF (1986) Biochemical engineering fundamentals, 2nd edn. Tata McGraw-Hill Education, Noida

Beck A (2011) Biosimilar, biobetter and next generation therapeutic antibodies. MAbs 3(2):107–110. https://doi.org/10.4161/mabs.3.2.14785 CrossRef

Bennett AD, Rhind SK, Lowe PA, Hentschel CCG (1984) Eur Pat Appl 0131363

Bhambure R, Kumar K, Rathore AS (2011) High-throughput process development for biopharmaceutical drug substances. Trends Biotechnol 29(3):127–135. https://doi.org/10.1016/j.tibtech.2010.12.001 CrossRef

Biopharma International Editors (2012) Considerations for successful upstream process development. BioPharm Int 25(7)

BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets (2002) This is a list of new full FDA approvals for biopharmaceutical products. Available from: http://www.biopharma.com/approvals.html

Bloomingburg GF, Bauer JS, Carta G, Byers CH (1991) Continuous separation of proteins by annular chromatography. Ind Eng Chem Res 30(5):1061–1010. https://doi.org/10.1021/ie00053a031 CrossRef

Bonham-Carter J, Shevitz J (2011) A brief history of perfusion bio manufacturing. BioProcess Int. 9(9):28–30

Brouns TM, Elliott ML, Van Wie BJ (1990) U.S. Patent No. 4,939,087. U.S. Patent and Trademark Office, Washington, DC

Buchacher A, Iberer G (2006) Purification of intravenous immunoglobulin G from human plasma – aspects of yield and virus safety. Biotechnol J 1(2):148–163. https://doi.org/10.1002/biot.200500037 CrossRef

Casey C, Gallos T, Alekseev Y, Ayturk E, Pearl S (2011) Protein concentration with single-pass tangential flow filtration (SPTFF). J Membr Sci 384(1-2):82–88. https://doi.org/10.1016/j.memsci.2011.09.004 CrossRef

Chen J, Tetrault J, Ley A (2008) Comparison of standard and new generation hydrophobic interaction chromatography resins in the monoclonal antibody purification process. J Chromatogr A 1177(2):272–281. https://doi.org/10.1016/j.chroma.2007.07.083 CrossRef

Cheryan M (1986) Ultrafiltration handbook. Technomic, Lancaster

Chisti Y, Moo-Young M (1986) Disruption of microbial cells for intracellular products. Enzym Microb Technol 8:194–204. https://doi.org/10.1016/0141-0229(86)90087-6 CrossRef

Chon JH, Zarbis-Papastoitsis G (2011) Advances in the production and downstream processing of antibodies. New Biotechnol 28(5):458–463. https://doi.org/10.1016/j.nbt.2011.03.015 CrossRef

Courtney M, Buchwalder A, Tessier LH, Jaye M, Benavente A, Ballard A, Kohli V, Lathe R, Tolstoshev P, Lecocq JP (1984) High-level production of biologically active human alpha 1-antitrypsin in Escherichia coli. 1984. Proc Natl Acad Sci U S A 81(3):669–663. https://doi.org/10.1073/pnas.81.3.669 CrossRef

Crapisi A, Lante A, Pasini G, Spettoli P (1993) Enhanced microbial cell lysis by the use of lysozyme immobilised on different carriers. Process Biochem 28(1):17–21. https://doi.org/10.1016/0032-9592(94)80031-6 CrossRef

Crommelin DJ, Storm G, Verrijk R, de Leede L, Jiskoot W, Hennink WE (2003) Shifting paradigms: biopharmaceuticals versus low molecular weight drugs. Int J Pharm 266(1-2):3–16. https://doi.org/10.1016/S0378-5173(03)00376-4 CrossRef

Dean CR, Ward OP (1992) The use of EDTA or polymyxin with lysozyme for the recovery of intracellular products from Escherichia coli. Biotechnol Tech 6(2):133–138. https://doi.org/10.1007/BF02438819 CrossRef

del Val IJ, Kontoravdi C, Nagy JM (2010) Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns. Biotechnol Prog 26(6):1505–1527. https://doi.org/10.1002/btpr.470 CrossRef

Dunnill P, Lilly MD (1974) Purification of enzymes using magnetic bioaffinity materials. Biotechnol Bioeng 16:987–990. https://doi.org/10.1002/bit.260160710 CrossRef

Durocher Y, Butler M (2009) Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol 20(6):700–707. https://doi.org/10.1016/j.copbio.2009.10.008 CrossRef

Eiberle MK, Jungbauer A (2010) Technical refolding of proteins: do we have freedom to operate? Biotechnol J 5(6):547–559. https://doi.org/10.1002/biot.201000001 CrossRef

Erikson RA (1984) Disk stack centrifuges in biotechnology. In: American Institute of Chemical Engineers, National Meeting, American Institute of Chemical Engineers, p 9

Ferreira AM, Faustino VFM, Mondal D, Coutinho JAP, Freire MG (2016) Improving the extraction and purification of immunoglobulin G by the use of ionic liquids as adjuvants in aqueous biphasic systems. J Biotechnol 236:166–175. https://doi.org/10.1016/j.jbiotec.2016.08.015 CrossRef

Fish B, Williams R (2007) Avoiding pitfalls in scaling up biopharmaceutical production. Pharm Technol Eur 19(10):29. doi: not available

Frenzel A, Bergemann C, Kohl G, Reinard T (2003) Novel purification system for 6xHis-tagged proteins by magnetic affinity separation. J Chromatogr A 793:325–329. https://doi.org/10.1016/S1570-0232(03)00332-5 CrossRef

Frost, Sullivan (2004) Strategic analysis of downstream processing. In: Biopharmaceutical production

Gagnon P (2006) Polishing methods for monoclonal IgG purification. In: Shukla AA, Etzel MR, Gadam S (eds) Process scale bioseparations for the biopharmaceutical industry. Taylor & Francis, New York, pp 491–505CrossRef

Gagnon P (2012) Technology trends in antibody purification. J Chromatogr A 1221:57–70. https://doi.org/10.1016/j.chroma.2011.10.034 CrossRef

Gary W (2000) Biopharmaceutical benchmarks. Nat Biotechnol 18:832–833. https://doi.org/10.1038/nbt.3040 CrossRef

Gary W (2003) Biopharmaceutical and pharmaceutical biotechnology. In: Biopharmaceuticals: biochemistry and biotechnology, 2nd edn. Wiley, Chichester

Ghose S, Hubbard B, Cramer SM (2006) Evaluation and comparison of alternatives to Protein A chromatography: mimetic and hydrophobic charge induction chromatographic stationary phases. J Chromatogr A 1122(1-2):144–152. https://doi.org/10.1016/j.chroma.2006.04.083 CrossRef

Ghose S, Jin M, Liu J, Hickey J (2009) Integrated polishing steps for monoclonal antibody purification. In: Gottschalk U (ed) Process scale purification of antibodies. Wiley, New York, pp 145–141CrossRef

Giovannini R, Freitag R (2001) Isolation of a recombinant antibody from cell culture supernatant: continuous annular versus batch and expanded-bed chromatography. Biotechnol Bioeng 73(6):522–529. https://doi.org/10.1002/bit.1087 CrossRef

Goeddel DV, Heyneker HL, Hozumi T, Arentzon R, Itakura K, Yansura DG, Ross MJ, Miozzari G, Crea R, Seeburg P (1979a) Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone. Nature 281(5732):544–548. https://doi.org/10.1038/281544a0 CrossRef

Goeddel DV, Kleid DG, Bolivar F, Heyneker HL, Yansura DG, Crea R, Hirose T, Kraszewski A, Itakura K, Riggs AD (1979b) Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc Natl Acad Sci USA 76(1):106–110. doi: not availableCrossRef

Gözke G, Kirschhöfer F, Heissler S, Trutnau M, Brenner-Weiss G, Ondruschka J, Obst U, Posten C (2012) Filtration kinetics of chitosan separation by electrofiltration. Biotechnol J 7(2):262–274. https://doi.org/10.1002/biot.201000466 CrossRef

Gronemeyer P, Ditz R, Strube J (2014) Trends in upstream and downstream process development for antibody manufacturing. Bioengineering 1(4):188–212. https://doi.org/10.3390/bioengineering1040188 CrossRef

Gueorguieva L, Palani S, Rinas U, Jayaraman G, Seidel-Morgenstern A (2011) Recombinant protein purification using gradient assisted simulated moving bed hydrophobic interaction chromatography. Part II: process design and experimental validation. J Chromatogr A 1218(37):6402–6411. https://doi.org/10.1016/j.chroma.2011.07.008 CrossRef

Hanke AT, Ottens M (2014) Purifying biopharmaceuticals: knowledge-based chromatographic process development. Trends Biotechnol 32(4):210–220. https://doi.org/10.1016/j.tibtech.2014.02.001 CrossRef

Harrison STL (2011) Cell disruption. In: Comprehensive biotechnology, 2nd edn. Elsevier, Oxford, pp 619–639CrossRef

Himeji D, Horiuchi T, Tsukamoto H, Hayashi K, Watanabe T, Harada M (2002) Characterization of caspase-8L: a novel isoform of caspase- 8 that behaves as an inhibitor of the caspase cascade. Blood 99:4070–4078. https://doi.org/10.1182/blood.V99.11.4070 CrossRef

Hodge G (2005) Media development for mammalian cell culture. Biopharm Int 18:54

Hofmann I, Schnolzer M, Kaufmann I, Franke WW (2002) Symplekin, a constitutive protein of karyo- and cytoplasmic particles involved in mRNA biogenesis in Xenopus laevis oocytes. Mol Biol Cell 13(5):1665–1676. https://doi.org/10.1091/mbc.01-12-0567 CrossRef

Hossler P, Khattak SF, Li ZJ (2009) Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 19(9):936–949. https://doi.org/10.1093/glycob/cwp079 CrossRef

Huddleston J, Veide A, Köhler K, Flanagan J, Enfors SO, Lyddiatt A (1991) The molecular basis of partitioning in aqueous two-phase systems. Trends Biotechnol 9(11):381–388. https://doi.org/10.1016/0167-7799(91)90130-A CrossRef

Huettmann H, Berkemeyer M, Buchinger W, Jungbauer A (2014) Preparative crystallization of a single chain antibody using an aqueous two-phase system. Biotechnol Bioeng 111(11):2192–2199. https://doi.org/10.1002/bit.25287 CrossRef

Iberer G, Schwinn H, Josic D, Jungbauer A, Buchacher A (2002) Continuous purification of a clotting factor IX concentrate and continuous regeneration by preparative annular chromatography. J Chromatogr 972(1):115–129. https://doi.org/10.1016/S0021-9673(02)01074-9 CrossRef

Itakura K, Hiroso T, Crea R, Riggs AD, Heyneker HL, Bolivar F, Boyer HW (1977) Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 198(4321):1056–1063. https://doi.org/10.1126/science.412251 CrossRef

Ivory CF, Gilmartin M, Gobie WA, McDonald CA, Zollars RL (1995) A hybrid centrifuge rotor for continuous bioprocessing. Biotechnol Prog 11(1):21–32. https://doi.org/10.1021/bp00031a003 CrossRef

Jayapal KP, Wlaschin KF, Hu WS, Yap MGS (2007) Recombinant protein therapeutics from CHO cells – 20 years and counting. Chem Eng Prog 103(10):40–47. doi: not available

Jozala AF, Geraldes DC, Tundisi LL, Feitosa VA, Breyer CA, Cardoso SL, Mazzola PG, Oliveira-Nascimento L, Rangel-Yagui CO, Magalhães PO, Oliveira MA, Pessoa A Jr (2016) Biopharmaceuticals from microorganisms: from production to purification. Braz J Microbiol 47(1):51–63. https://doi.org/10.1016/j.bjm.2016.10.007 CrossRef

Jungbauer A (2013) Continuous downstream processing of biopharmaceuticals. Trends Biotechnol 31(8):479–492. https://doi.org/10.1016/j.tibtech.2013.05.011 CrossRef

Jungbauer A, Kaar W (2007) Current status of technical protein refolding. J Biotechnol 128(3):587–596. https://doi.org/10.1016/j.jbiotec.2006.12.004 CrossRef

Kato Y, Nakamura K, Kitamura T, Hasegawa M, Sasaki H (2004) Hydrophobic interaction chromatography at low salt concentration for the capture of monoclonal antibodies. J Chromatogr A 1036(1):45–50. https://doi.org/10.1016/j.chroma.2004.02.009 CrossRef

Kennedy RM (2005) Expanded-bed adsorption chromatography. Curr Protoc Protein Sci Jun; Chapter 8: Unit 8:8. https://doi.org/10.1002/0471140864.ps0808s40 CrossRef

Kramberger P, Urbas L, Štrancar A (2015) Downstream processing and chromatography based analytical methods for production of vaccines, gene therapy vectors, and bacteriophages. Hum Vaccin Immunother 11(4):1010–1021. https://doi.org/10.1080/21645515.2015.1009817 CrossRef

Kwon JS-II, Nayhouse M, Christofides PD, Orkoulas G (2014) Modeling and control of crystal shape in continuous protein crystallization. Chem Eng Sci 107:47–57. https://doi.org/10.1016/j.ces.2013.12.005 CrossRef

Lain B, Cacciuttolo MA, Zarbis-Papastoitsis G (2009) Development of a high-capacity Mab capture step based on cation-exchange chromatography. BioProcess Int 7(5):26–34

Lander R, Daniels C, Meacle F (2005) Efficient, scalable clarification of diverse bioprocess streams. Bioprocess Int 11:32–40

Langer ES (2011) Trends in perfusion bioreactors: will perfusion be the next revolution in bioprocessing? BioProcess Int. 9(10):18–22

Larsson PO (1994) Magnetically enhanced phase separation. Methods Enzymol 228:112–117. doi: not availableCrossRef

Lebreton B, Brown A, van Reis R (2008) Application of high-performance tangential flow filtration (HPTFF) to the purification of a human pharmaceutical antibody fragment expressed in Escherichia coli. Biotechnol Bioeng 100(5):964–974. https://doi.org/10.1002/bit.21842 CrossRef

Li F, Vijayasankaran N, Shen AY, Kiss R, Amanullah A (2010) Cell culture processes for monoclonal antibody production. MAbs 2(5):466–479. https://doi.org/10.4161/mabs.2.5.12720 CrossRef

Lin N, Mascarenhas J, Sealover NR, George HJ, Brooks J, Kayser KJ, Gau B, Yasa I, Azadi P, Archer-Hartmann S (2015) Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression. Biotechnol Prog 31(2):334–346. https://doi.org/10.1002/btpr.2038 CrossRef

Liu HF, Ma J, Winter C, Bayer R (2010) Recovery and purification process development for monoclonal antibody production. MAbs 2(5):480–499. https://doi.org/10.4161/mabs.2.5.12645 CrossRef

Liu Z, Wickramasinghe SR, Qian X (2017) Membrane chromatography for protein purifications from ligand design to functionalization. Sep Sci Technol 52:299–319. https://doi.org/10.1080/01496395.2016.1223133 CrossRef

Lowe CR (2001) Combinatorial approaches to affinity chromatography. Curr Opin Chem Biol 5(3):248–256. https://doi.org/10.1016/S1367-5931(00)00199-X CrossRef

Machold C, Schlegl R, Buchinger W, Jungbauer A (2005) Continuous matrix assisted refolding of a-lactalbumin by ion exchange chromatography with recycling of aggregates combined with ultradiafiltration. J Chromatogr A 1080(1):29–42. https://doi.org/10.1016/j.chroma.2005.03.018 CrossRef

Mahajan E, George A, Wolk B (2012) Improving affinity chromatography resin efficiency using semi-continuous chromatography. J Chromatogr A 1227:154–162. https://doi.org/10.1016/j.chroma.2011.12.106 CrossRef

Martinez Cristancho CA, David F, Franco-Lara E, Seidel-Morgenstern A (2013) Discontinuous and continuous purification of single-chain antibody fragments using immobilized metal ion affinity chromatography. J Biotechnol 163(2):233–242. https://doi.org/10.1016/j.jbiotec.2012.08.022 CrossRef

Middelberg A (1995) Process-scale disruption of microorganisms. Biotechnol Adv 13(3):491–551. https://doi.org/10.1016/0734-9750(95)02007-P CrossRef

Mitragotri S, Burke PA, Langer R (2014) Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov 13(9):655–652. https://doi.org/10.1038/nrd4363 CrossRef

Mun S, Yi X, Kim JH, Wang NHL (2003) Optimal design of a size-exclusion tandem simulated moving bed for insulin purification. Ind Eng Chem Res 42(9):1977–1993. https://doi.org/10.1021/ie020680+ CrossRef

Ngantung FA, Miller PG, Brushett FR, Tang GL, Wang DI (2006) RNA interference of sialidase improves glycoprotein sialic acid content consistency. Biotechnol Bioeng 95(1):106–119. https://doi.org/10.1002/bit.20997 CrossRef

Nishiya Y, Hibi T, Oda JL (2002) A purification method of the diagnostic enzyme Bacillus uricase using magnetic beads and nonspecific protease. Protein Expr Purif 25:426–429. https://doi.org/10.1016/S1046-5928(02)00022-0 CrossRef

Odabasi M, Denizli A (2004) Cibacron Blue F3GA-attached magnetic poly(2-hydroxyethyl methacrylate) beads for human serum albumin adsorption. Polym Int 53:332–338. https://doi.org/10.1002/pi.1305 CrossRef

Ozdural AR et al (2007) A novel technology for virus vaccine purification: modeling and operation of continuous annular chromatography unit. In: AIChE annual meeting: 2007 Spring meeting and 3rd global congress on process safety. American Institute of Chemical Engineers, p 18

Parmar HC (2006) Biopharmaceuticals market overview In: Pharmatech.com. Pharmaceutical Technology Europe 18(3). https://economictimes.indiatimes.com/industry/healthcare/biotech/india-launches-flagship-program-to-boost-biopharma-production/articleshow/59390777.cms

Peeva L, da Silva Burgal J, Valtcheva I, Livingston AG (2014) Continuous purification of active pharmaceutical ingredients using multistage organic solvent nanofiltration membrane cascade. Chem Eng Sci 116:183–194. https://doi.org/10.1016/j.ces.2014.04.022 CrossRef

Pennica D, Hayflick JS, Bringman TS, Palladina MA, Goeddel DV (1985) Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc Natl Acad Sci U S A 82:6060–6064. doi:not availableCrossRef

Pirrung SM, van der Wielen LAM, van Beckhoven RFWC, van de Sandt EJAX, Eppink MHM, Ottens M (2017) Optimization of biopharmaceutical downstream processes supported by mechanistic models and artificial neural networks. Biotechnol Prog 33(3):696–707. https://doi.org/10.1002/btpr.2435 CrossRef

Rajendran A, Paredes G, Mazzotti M (2009) Simulated moving bed chromatography for the separation of enantiomers. J Chromatog A 1216(4):709–738. https://doi.org/10.1016/j.chroma.2008.10.075 CrossRef

Rathore AS, Agarwal H, Sharma AK, Pathak M, Muthukumar S (2015) Continuous processing for production of biopharmaceuticals. Prep Biochem Biotechnol 45(8):836–849. https://doi.org/10.1080/10826068.2014.985834 CrossRef

Rathore AS, Kumar D, Kateja N (2018) Recent developments in chromatographic purification of biopharmaceuticals. Biotechnol Lett 40(6):1–11. https://doi.org/10.1007/s10529-018-2552-1 CrossRef

Roque AC, Lowe CR, Taipa MA (2004) Antibodies and genetically engineered related molecules: production and purification. Biotechnol Prog 20(3):639–654. https://doi.org/10.1021/bp030070k CrossRef

Ruanjaikaen K, Zydney AL (2011) Purification of singly-pegylated α-lactalbumin using charged ultrafiltration membranes. Biotechnol Bioeng 108:822–829. https://doi.org/10.1002/bit.22991 CrossRef

Saboya LV, Maillard MB, Lortal S (2003) Efficient mechanical disruption of Lactobacillus helveticus, Lactococcus lactis and Propionibacterium freudenreichii by a new high-pressure homogenizer and recovery of intracellular aminotransferase activity. J Ind Microbiol Biotechnol 30(1):1–5. https://doi.org/10.1007/s10295-002-0011-3 CrossRef

Safarik I, Safarikova M (1993) Batch isolation of hen egg white lysozyme with magnetic chitin. J Biochem Biophys Methods 27:327–330. https://doi.org/10.1016/0165-022X(93)90013-E CrossRef

Saraswat M, Musante L, Ravidá A, Shortt B, Byrne B, Holthofer H (2013) Preparative purification of recombinant proteins: current status and future trends. Biomed Res Int 2013:312709. https://doi.org/10.1155/2013/312709 CrossRef

Schafer F, Romer U, Emmerlich M, Blumer J, Lubenow H, Steinert K (2002) Automated high-throughput purification of 6xHis-tagged proteins. J Biomol Tech 13:131–142. doi:not available

Schoemaker JM, Brasnett AH, Marston FA (1985) Examination of calf prochymosin accumulation in Escherichia coli: disulphide linkages are a structural component of prochymosin-containing inclusion bodies. EMBO J 4(3):775–780. doi:not availableCrossRef

Schoner RG, Ellis LF, Schoner BE (1985) Isolation and purification of protein granules from Escherichia coli cells overproducing bovine growth hormone. Bio Technol 3:151–154. https://doi.org/10.1038/nbt0285-151 CrossRef

Schuster M, Wasserbauer E, Ortner C, Graumann K, Jungbauer A, Hammerschmid F, Werner G (2000) Short cut of protein purification by integration of cell-disrupture and affinity extraction. Bioseparation 9(2):59–67. https://doi.org/10.1023/A:100813591 CrossRef

Scott JH, Schekman R (1980) Lyticase: endoglucanase and protease activities that act together in yeast cell lysis. J Bacteriol 142(2):414–423. doi:not available

Shao S, Gross V, Yan W, Guo T, Lazarev A, Abersold R (2015) Hands-free sample homogenisation and protein extraction from small tissue biopsy samples using pressure cycling technology and PCT micropestle (poster). In: US HUPO 2015 Conference, Tempe, AZ. http://www.pressurebiosciences.com/documents?task=document.viewdoc&id=64

Shinkai M, Kamihira M, Honda H, Kobayashi T (1992) Rapid purification of monoclonal antibody with functional magnetite particles. Kag Kog Ronbunshu 18:256–259. https://doi.org/10.1252/kakoronbunshu.18.256 CrossRef

Shukla AA, Hinckley P (2008) Host cell protein clearance during protein A chromatography: Development of an improved column wash step. Biotechnol Prog 24(5):1115–1121. https://doi.org/10.1002/btpr.50 CrossRef

Shukla AA, Thömmes J (2010) Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends Biotechnol 28(5):253–261. https://doi.org/10.1016/j.tibtech.2010.02.001 CrossRef

Shukla AA, Hubbard B, Tressel T, Guhan S, Low D (2007) Downstream processing of monoclonal antibodies – application of platform approaches. J Chromatogr B Anal Technol Biomed Life Sci 848(1):28–39. https://doi.org/10.1016/jchromb.2006.09.026 CrossRef

Siew WE, Livingston AG, Ates C, Merschaert A (2013) Continuous solute fractionation with membrane cascades – a high productivity alternative to diafiltration. Sep Purif Technol 102:1–14. https://doi.org/10.1016/j.seppur.2012.09.017 CrossRef

Strohl WR (2015) Fusion proteins for half-life extension of biologics as a strategy to make biobetters. BioDrugs 29(4):215–239. https://doi.org/10.1007/s40259-015-0133-6 CrossRef

Szoka PR, Schreiber AB, Chan H, Murthy J (1986) A general method for retrieving the components of a genetically engineered fusion protein. DNA 5(1):11–20. https://doi.org/10.1089/dna.1986.5.11 CrossRef

Tarrant RD, Velez-Suberbie ML, Tait AS, Smales CM, Bracewell DG (2012) Host cell protein adsorption characteristics during protein A chromatography. Biotechnol Prog 28(4):1037–1044. https://doi.org/10.1002/btpr.1581 CrossRef

Top drugs by sales revenue in 2015: Who sold the biggest blockbuster drugs? (2016) The PharmaCompass Newsletter. http://www.pharmacompass.com/radiocompass-blog/top-drugs-by-sales-revenue-in-2015-whosold-thebiggest-blockbuster-drugs

Tsumoto K, Ejima D, Nagase K, Arakawa T (2007) Arginine improves protein elution in hydrophobic interaction chromatography. The cases of human interleukin-6 and activin-A. J Chromatogr A 1154(1–2):81–86. https://doi.org/10.1016/j.chroma.2007.02.061 CrossRef

van Reis R, Zydney A (2007) Bioprocess membrane technology. J Membr Sci 297:16–50. https://doi.org/10.1016/j.memsci.2007.02.045 CrossRef

van Reis R, Gadam S, Frautschy LN, Orlando S, Goodrich EM, Saksena S, Kuriyel R, Simpson CM, Pearl S, Zydney AL (1997) High performance tangential flow filtration. Biotechnol Bioeng 56(1):71–82. https://doi.org/10.1002/(SICI)1097-0290(19971005)56:1<71::AID-BIT8>3.0.CO;2-S

Varma SK (2009) An overview of biopharmaceutical industry in India. Pharmabiz Chronicle Specials. http://saffron.pharmabiz.com/article/detnews.asp?articleid=53092&sectionid=50

Wang X, Rivière I (2016) Clinical manufacturing of CAR T cells: foundation of a promising therapy. Mol Ther Oncolyt 3:16015. https://doi.org/10.1038/mto.2016.15 CrossRef

Warikoo V, Godawat R, Brower K, Jain S, Cummings D, Simons E, Johnson T, Walther J, Yu M, Wright B, McLarty J, Karey KP, Hwang C, Zhou W, Riske F, Konstantinov K (2012) Integrated continuous production of recombinant therapeutic proteins. Biotechnol Bioeng 109(12):3018–3029. https://doi.org/10.1002/bit.24584 CrossRef

Watt JG (1970) Automatically controlled continuous recovery of plasma protein fractions for clinical use. A preliminary report. Vox Sang 18(1):42–61. https://doi.org/10.1111/j.1423-0410.1970.tb01428x CrossRef

Wellhoefer M, Sprinzl W, Hahn R, Jungbauer A (2013) Continuous processing of recombinant proteins: integration of inclusion body solubilization and refolding using simulated moving bed size exclusion chromatography with buffer recycling. J Chromatogr A 1319:107–117. https://doi.org/10.1016/j.chroma.2013.10.039 CrossRef

Wikstrom P, Flygare S, Grondalen A, Larsson PO (1987) Magnetic aqueous two-phase separation: a new technique to increase rate of phase-separation, using dextran-ferrofluid or larger iron oxide particles. Anal Biochem 1(2):331–339. https://doi.org/10.1016/0003-2697(87)90173-4s CrossRef

Wilson AW, Neumann PJ (2012) The cost-effectiveness of biopharmaceuticals: a look at the evidence. MAbs 4(2):281–288. https://doi.org/10.4161/mabs.4.2.18812 CrossRef

Winkler ME, Blaber M, Bennett GL, Holmes W, Vehar GA (1985) Purification and characterization of recombinant urokinase from Escherichia coli. Bio Technol 3:990–1000. https://doi.org/10.1038/nbt1185-990 CrossRef

Yamane-Ohnuki N, Kinoshita S, Inoue-Urakubo M, Kusunoki M, Iida S, Nakano R, Wakitani M, Niwa R, Sakurada M, Uchida K, Shitara K, Satoh M (2004) Establishment of FUT8 knockout Chinese Hamster Ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody dependent cellular cytotoxicity. Biotechnol Bioeng 87(5):614–622. https://doi.org/10.1002/bit.20151 CrossRef

Zang Y, Kammerer B, Eisenkolb M, Lohr K, Kiefer H (2011) Towards protein crystallization as a process step in downstream processing of therapeutic antibodies: screening and optimization at microbatch scale. PLoS One 6(9):1–8. https://doi.org/10.1371/journal.pone.0025282 CrossRef

Zhou JX, Tressel T (2006) Basic concepts in Q membrane chromatography for large-scale antibody production. Biotechnol Prog 22(2):341–349. https://doi.org/10.1021/bp050425v CrossRef

Zhu J (2012) Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 30(5):1158–1170. https://doi.org/10.1016/j.biotechadv.2011.08.022 CrossRef

Zydney AL (2015) Continuous downstream processing for high value biological products: a review. Biotechnol Bioeng 113(3):465–475. https://doi.org/10.1002/bit.25695 CrossRef

Zydney AL, van Reis R (2001) High performance tangential flow filtration. In: Wang WK (ed) Membrane separations in biotechnology, 2nd edn. Marcel Dekker, New York, pp 277–298

Titel: Downstream Processing for Biopharmaceuticals Recovery
verfasst von: Anu Mehta
Verlag: Springer International Publishing
Buch: Pharmaceuticals from Microbes
Print ISBN: 978-3-030-01880-1

Electronic ISBN: 978-3-030-01881-8

Copyright-Jahr: 2019
DOI: https://doi.org/10.1007/978-3-030-01881-8_6